Highly potent MyoAAV4A vector reverses GSD III pathology in aged mice and enables long-term muscle disease correction in young adult mice.
- DOI
- 10.1016/j.omta.2026.201800
- Published
- 2026 Sep 10
- Container
- Molecular therapy. Advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omta.2026.201800,
title = {Highly potent MyoAAV4A vector reverses GSD III pathology in aged mice and enables long-term muscle disease correction in young adult mice.},
author = {Liao KA and Yi H and Zhang H and Eisner W and Young SP and Sun B},
year = {2026},
journal = {Molecular therapy. Advances},
doi = {10.1016/j.omta.2026.201800},
url = {https://doi.org/10.1016/j.omta.2026.201800}
}RIS
TY - JOUR TI - Highly potent MyoAAV4A vector reverses GSD III pathology in aged mice and enables long-term muscle disease correction in young adult mice. AU - Liao KA AU - Yi H AU - Zhang H AU - Eisner W AU - Young SP AU - Sun B PY - 2026 JO - Molecular therapy. Advances DO - 10.1016/j.omta.2026.201800 UR - https://doi.org/10.1016/j.omta.2026.201800 ER -
APA
KA, L., H, Y., H, Z., W, E., SP, Y., & B, S. (2026). Highly potent MyoAAV4A vector reverses GSD III pathology in aged mice and enables long-term muscle disease correction in young adult mice.. Molecular therapy. Advances. https://doi.org/10.1016/j.omta.2026.201800
Source records
- pubmed · retrieved 2026-09-26T09:14:21.668Z